Results 181 to 190 of about 349,564 (336)

A sustainable business ecosystem: a case study demonstrating biochar's potential

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Kivijakola Juuso, Erkheikki Eemeli, Lukka Viljo, Tervonen Pekka, Harri Haapasalo   +4 more
wiley   +1 more source

Diverging regulatory DNA in adaptive medical AI: US agility and EU accountability in lifecycle governance. [PDF]

Front Med (Lausanne)
Lee JH, Choi B, Jeong K, Suh SW, Rhee H, Kim JH, Son DS.   +6 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Optimizing renewable energy investments using artificial intelligence-based multi-facet fuzzy decision models. [PDF]

Sci Rep
Dinçer H, Yüksel S, Aksoy T, Hacıoğlu Ü.   +3 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Software Lifecycle Models in Trilinos

, 2014
Heroux Michael, Bartlett Ross, Willenbring James   +2 more
openalex   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

Academic misconduct appeal services in China: Platform logics, self‐platformization and implications for integrity education

British Educational Research Journal, EarlyView.
Abstract Academic misconduct appeal services have quietly emerged within China's education marketplace, with commercial agencies promoting themselves on social media to assist international students facing misconduct hearings. While existing research on academic integrity has emphasized prevention and detection, far less attention has been paid to what
Gengyan Tang, Sarah Elaine Eaton, Wei Cai   +2 more
wiley   +1 more source

People process technology and operations framework for establishing AI governance in healthcare organizations. [PDF]

NPJ Digit Med
Kim JY, Hasan A, Balu S, Sendak M.
europepmc   +1 more source

Effects of Benzo (a) Pyrene and 2,2′,4,4′-Tetrabromodiphenyl Ether Exposure on the Thyroid Gland in Rats by Attenuated Total Reflection Fourier-Transform Infrared Spectroscopy

ACS Omega
QiuFeng Lao, LiJun Yang, ShuZhen Liu, XiaoJun Ma, DeChan Tan, JinBo Li, BaoYi Liao, YuanFeng Wei, WeiYi Pang, Camilo L. M. Morais, Hui Liu   +10 more
doaj   +1 more source